End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 USD | 0.00% | +8.75% | -7.94% |
Feb. 22 | Notable Labs, Ltd. Advances Volasertib Phase 2 Program Utilizing Proprietary Predictive Precision Medicine Platform-Guided Enrollment | CI |
Jan. 09 | Top Premarket Gainers | MT |
Chart calendar Notable Labs, Ltd.
Upcoming events on Notable Labs, Ltd.
Past events on Notable Labs, Ltd.
2023-05-15 04:01 pm | Q1 2023 Earnings Release |
2023-03-14 08:00 am | Q4 2022 Earnings Release |
2023-02-23 08:30 am | Vascular Biogenics Ltd. and Notable Labs Merger Call |
2022-11-14 04:05 pm | Q3 2022 Earnings Release |
2022-08-15 04:05 pm | Interim 2022 Earnings Release |
2022-06-08 03:00 pm | Jefferies Healthcare Conference |
2022-06-02 | American Society of Clinical Oncology Meeting |
2022-05-22 | H.C. Wainwright Global Life Sciences Investment Conference |
2022-05-17 08:30 am | Q1 2022 Earnings Call |
2022-05-17 07:00 am | Q1 2022 Earnings Release |
2022-05-12 02:30 am | Biomed Israel Conference |
2022-05-11 01:00 pm | LifeSci Partners Immunology & Inflammation Symposium |
2022-05-08 05:30 pm | IMMUNOLGY Meeting |
2022-04-11 12:00 pm | Investor Meeting - KOL |
2022-03-23 08:30 am | FY 2021 Earnings Call |
2022-03-23 07:00 am | FY 2021 Earnings Release |
2022-03-16 08:40 am | Oppenheimer Healthcare Conference |
2022-03-14 12:30 pm | Roth Capital Partners Conference |
2022-02-13 | Bio CEO & Investor Conference |
2022-02-10 10:00 am | Guggenheim Virtual Oncology Conference |
Annual results
Fiscal Period | December | 2022 | 2023 |
---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -14,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -14,5 |
Net income Million USD | Released Forecast Spread | -14,4 | -14,5 |
EPS USD | Released Forecast Spread | -1,38 | -1,62 |
Announcement Date | 01/09/23 | - |
Quarterly results
Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,12 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -1,75 -3,71 52.78% | -3,88 | ||||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2,89 -3,71 178.06% | -3,87 | ||||
Net income Million USD | Released Forecast Spread | 2,89 -3,71 178.06% | -3,87 | ||||
EPS USD | Released Forecast Spread | 0,19 -0,41 146.34% | -0,43 | -0,37 | -0,43 | -0,58 | -0,63 |
Announcement Date | 29/11/23 | - | - | - | - | - |
Past sector events for Notable Labs, Ltd.
Today | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
2024-03-27 07:00 am | ALTIMMUNE, INC.: Q4 2023 Earnings Release |
2024-03-26 | LEPU BIOPHARMA CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 | REMEGEN CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 | PHILOGEN S.P.A.: Q4 2023 Earnings Release |
2024-03-26 | ASCENTAGE PHARMA GROUP INTERNATIONAL: Q4 2023 Earnings Release |
2024-03-26 01:16 pm | KEYMED BIOSCIENCES INC.: Q4 2023 Earnings Release |
2024-03-24 | IMMUNEONCO BIOPHARMACEUTICALS (SHANGHAI) INC.: Q4 2023 Earnings Release |
2024-03-24 | SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
2024-03-21 04:01 pm | DIANTHUS THERAPEUTICS, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Notable Labs, Ltd. - Nasdaq
- Calendar Notable Labs, Ltd.